G.H. Blijham - Concepedia

Author

G.H. Blijham

Also Known As

G BLIJHAM, G Blijham, G H Blijham, G. Blijham, G. H. BLIJHAM, G. H. Blijham, G.H Blijham, G.H. BLIJHAM, G.H. Blijham, GH BLIJHAM

124

Publications

5.8K

Citations

H-Index

114

Concepts

All Affiliations

Maastricht University Medical Centre University Medical Center Utrecht Utrecht University Maastricht University Heidelberg University

About

G.H. Blijham is an author at Maastricht University Medical Centre specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	40	3.8K
2	Health Sciences	5	5	422
3	Nursing	3	3	164
4	Education	1	1	14
5	Engineering	1	1	157

G.H. Blijham

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients C.-H. Köhne, David Cunningham, Francesco Di Costanzo, Annals of Oncology Clinical DeterminantsSurgical OncologyMultivariate AnalysisMedicineColorectal Cancer	2002	456
Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin‐embedded tissue B. Schütte, M. Reynders, Fred T. Bosman, Cytometry	1985	375
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Harry Bleiberg, Thierry Conroy, B Paillot, European Journal of Cancer Esophageal CancerGastrointestinal OncologyMedicinePathologyPhase Ii Study	1997	347
Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium A.W Griffioen, C.A. Damen, G.H. Blijham, Blood	1996	296
Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Arjan W. Griffioen, C.A. Damen, Stefano Martinotti, PubMed Cell AdhesionImmunologyAngiogenic FactorsTumor BiologyAngiogenesis	1996	284
REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT A.Th. van Holten-Verzantvoort, O. L. M. Bijvoet, J. Hermans, The Lancet Bone DiseaseBreast OncologyBone HealthMedicineBreast Cancer	1987	203
Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer Alexander de Graeff, J.R.J. de Leeuw, Wynand J.G. Ros, European Journal of Cancer Family MedicineQuality Of LifeNeck CancerLife AssessmentCancer Epidemiology	2001	197
Palliative pamidronate treatment in patients with bone metastases from breast cancer. A.Th. van Holten-Verzantvoort, Hidde M. Kroon, O. L. M. Bijvoet, Journal of Clinical Oncology	1993	197
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. F J G M Kubben, A Peeters-Haesevoets, L.G.J.B. Engels, Gut Colorectal SurgeryGastroenterologyPathologyCell ProliferationS Phase	1994	196
Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer Pascal Piedbois, Marc Buyse, G.H. Blijham, Journal of Clinical Oncology OncologyBiochemical ModulationGastrointestinal OncologyMedicineRandomized Trials	1994	191

Page 1